Cargando…
P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429101/ http://dx.doi.org/10.1097/01.HS9.0000847688.01787.13 |
_version_ | 1784779329887010816 |
---|---|
author | Ma, L. Dou, Y. Liu, R. Xu, T. Yang, F. Xue, F. Zheng, P. Feng, S. Guo, Y. Shi, H. Deng, B. Ke, X. Hu, K. |
author_facet | Ma, L. Dou, Y. Liu, R. Xu, T. Yang, F. Xue, F. Zheng, P. Feng, S. Guo, Y. Shi, H. Deng, B. Ke, X. Hu, K. |
author_sort | Ma, L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9429101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94291012022-08-31 P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA Ma, L. Dou, Y. Liu, R. Xu, T. Yang, F. Xue, F. Zheng, P. Feng, S. Guo, Y. Shi, H. Deng, B. Ke, X. Hu, K. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429101/ http://dx.doi.org/10.1097/01.HS9.0000847688.01787.13 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Ma, L. Dou, Y. Liu, R. Xu, T. Yang, F. Xue, F. Zheng, P. Feng, S. Guo, Y. Shi, H. Deng, B. Ke, X. Hu, K. P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA |
title | P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA |
title_full | P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA |
title_fullStr | P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA |
title_full_unstemmed | P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA |
title_short | P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA |
title_sort | p1206: gastrointestinal bleeding significantly reduced the efficacy and survival of cd19 car-t cell therapy in patients with gastrointestinal tract involvement of refractory/relapsed b-cell lymphoma |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429101/ http://dx.doi.org/10.1097/01.HS9.0000847688.01787.13 |
work_keys_str_mv | AT mal p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT douy p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT liur p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT xut p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT yangf p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT xuef p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT zhengp p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT fengs p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT guoy p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT shih p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT dengb p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT kex p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma AT huk p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma |